DUCE 发表于 2025-3-23 10:53:22
http://reply.papertrans.cn/24/2384/238307/238307_11.pngnocturnal 发表于 2025-3-23 16:06:11
http://reply.papertrans.cn/24/2384/238307/238307_12.png民间传说 发表于 2025-3-23 21:22:03
Revascularization for Coronary Artery Disease: Principle and Challenges,rtant determinants of patient outcomes. Multidisciplinary decision-making should analyze current evidence, considering the clinical condition of patients, and determine the safety and necessity for coronary revascularization with either PCI or CABG. For coronary artery disease with more complex lesiOstrich 发表于 2025-3-24 01:08:06
Drug Discovery for Coronary Artery Disease,ing atherothrombosis opens a new era of therapeutic discovery that targets inflammation. Chinese traditional medicine and cardiac regeneration are also discussed. Human genetics studies of CAD and further delineation of key determinants/pathways underlying the residual risk of CAD under current stanPLAYS 发表于 2025-3-24 04:24:14
http://reply.papertrans.cn/24/2384/238307/238307_15.pngdelusion 发表于 2025-3-24 06:57:15
Welcome Address by the Conference Chairmant patients. While cumulating studies have focused on optimizing pharmacological therapy (referring to nitrates, beta-blockers, calcium channel blockers, antiplatelet agents, ACEI/ARB, statins, etc.), education, habitual modification, and social support matters a lot for reducing cardiac morbidity an蘑菇 发表于 2025-3-24 14:08:04
G. F. Bennett,E. C. Greiner,W. Threlfallrtant determinants of patient outcomes. Multidisciplinary decision-making should analyze current evidence, considering the clinical condition of patients, and determine the safety and necessity for coronary revascularization with either PCI or CABG. For coronary artery disease with more complex lesispondylosis 发表于 2025-3-24 15:23:26
http://reply.papertrans.cn/24/2384/238307/238307_18.png使苦恼 发表于 2025-3-24 19:25:40
0065-2598 owing chapters provide an overview of three major categories of coronary artery disease drugs, which target thrombosis (Chapter 4), lipid metabolism (Chapter 5), and hypertension (Chapter 6). Heart failure cons978-981-15-2519-3978-981-15-2517-9Series ISSN 0065-2598 Series E-ISSN 2214-8019delegate 发表于 2025-3-25 00:55:39
http://reply.papertrans.cn/24/2384/238307/238307_20.png